EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Preferential accumulation and export of high molecular weight FGF-2 by rat cardiac non-myocytes


Cardiovascular Research 89(1): 139-147
Preferential accumulation and export of high molecular weight FGF-2 by rat cardiac non-myocytes
fibroblast growth factor-2 (FGF-2), implicated in paracrine induction of cardiac hypertrophy, is translated as high molecular weight (Hi-FGF-2) and low molecular weight (Lo-FGF-2) isoforms. Paracrine activities are assigned to Lo-FGF-2, whereas Hi-FGF-2 is presumed to have nuclear functions. In this work, we re-examined the latter presumption by asking whether: cardiac non-myocytes (CNMs) accumulate and export Hi-FGF-2 in response to pro-hypertrophic [angiotensin II (Ang II)] stimuli; an unconventional secretory pathway requiring activated caspase-1 affects Hi-FGF2 export; and secreted Hi-FGF-2 is pro-hypertrophic. using neonatal rat heart-derived cultures and immunoblotting, we show that CNMs accumulated over 90% Hi-FGF-2, at levels at least five-fold higher than cardiomyocytes (CMs). Pro-hypertrophic agents (Ang II, endothelin-1, and isoproterenol) up-regulated CNM-associated Hi-FGF-2. The Ang II effect was mediated by Ang II receptor-1 but not Ang II receptor-2 as it was blocked by losartan but not PD123319. CNM-derived Hi-FGF-2 was detected in two extracellular pools: in conditioned medium from Ang II-stimulated CNMs and in association with the cell surface/matrix, eluted with a gentle 2 M NaCl wash of the cell monolayer. Conditioned medium from Ang II-treated CNMs increased neonatal CM size, an effect prevented by anti-FGF-2-neutralizing antibodies. The caspase-1 inhibitor YVAD prevented the Ang II-induced release of Hi-FGF-2 to both extracellular pools. CNMs are major producers of Hi-FGF-2, up-regulated by hypertrophic stimuli and exported to the extracellular environment by a mechanism requiring caspase-1 activity, suggesting a link to the innate immune response. Hi-FGF-2 is likely to promote paracrine induction of myocyte hypertrophy in vivo.


Accession: 055116715

PMID: 20696821

DOI: 10.1093/cvr/cvq261



Related references

High and preferential accumulation in the kidneys of low molecular weight proteins. Renal Failure 11(2-3): 158, 1989

Transient appearance of potassium iodide ki stable high molecular weight proteins associated with developing myofibrils in embryonic cardiac myocytes. Journal of Cell Biology 105(4 PART 2): 285A, 1987

High-molecular-weight polyethylene glycol protects cardiac myocytes from hypoxia- and reoxygenation-induced cell death and preserves ventricular function. American Journal of Physiology. Heart and Circulatory Physiology 300(5): H1733-H1742, 2011

Preferential affinity of high molecular weight high mobility group non-histone chromatin proteins for single-stranded DNA. Journal of Biological Chemistry 254(13): 5569-5572, 1979

Release of lipoprotein lipase from cardiac myocytes by low-molecular weight heparin. Lipids 28(1): 59-61, 1993

Preferential increase in high-molecular weight adiponectin after niacin. Atherosclerosis 198(1): 179-183, 2007

The low molecular weight GTPase Rho regulates actin myofilament organization in cardiac myocytes. Journal of Molecular & Cellular Cardiology 29(6): A163, 1997

High molecular weight tau: preferential localization in the peripheral nervous system. Journal of Cell Science 100: 55-60, 1991

Regulation of hypertrophic growth in cardiac myocytes by the low molecular weight GTPase Rho and its effector Rho kinase. FASEB Journal 12(8): A1372, April 24, 1998

An epsilonPKC-selective inhibitor attenuates back phosphorylation of a low molecular weight protein in cardiac myocytes. Cellular Signalling 15(1): 123-130, 2002